Furthermore, anti-NGF antibodies have been shown to reduce cell migration by up to 40% in two prostate cancer cell lines (DU-145 and PC-3), which have lost expression of p75NTR and retained TrkA tyrosine kinase activity [125]. The gene discussed is NTRK1; the disease is Familial prostate cancer.